Coronavirus Vaccine | NDTV-Dettol Banega Swasth Swachh India

Serum Institute Of India Partners With The Gates Foundation For Manufacturing 100 Million Doses Of COVID-19 Vaccine

The Serum Institute of India (SII) has collaborated with Gavi, The Vaccine Alliance and the Bill and Melinda Gates Foundation to manufacture and deliver up to...

COVID-19 Vaccine Not Designed To Eradicate The Virus But To Mitigate The Virus: Expert

Coronavirus Vaccine4 years ago

COVID-19 Vaccine Not Designed To Eradicate The Virus But To Mitigate The Virus: Expert

Dr Faheem Younus, Chief of Infectious Diseases in Maryland school of Medicine, tells NDTV in an exclusive interview, that there’s ‘much to be optimistic about’ in...

India's Case Fatality Rate (CFR) now stands at 2.11 per cent

Coronavirus Vaccine4 years ago

DCGI Gives Nod To Serum Institute To Hold Phase II, III COVID Vaccine Trials

With the aim to expedite the COVID-19 vaccine development, the Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to...

A Modern Technique, eVIN, Ensured Essential Immunisation Services: Healthy Ministry

Coronavirus Vaccine4 years ago

A Modern Technique, eVIN, Ensured Essential Immunisation Services: Healthy Ministry

The Electronic Vaccine Intelligence Network (eVIN) is an innovative technological solution that aims to provide real-time information on vaccine stocks and flows, and storage temperatures across...

Hope For Vaccine: Novel Coronavirus Strains Show Little Variability, Study Finds

Coronavirus Vaccine4 years ago

Hope For Vaccine: Novel Coronavirus Strains Show Little Variability, Study Finds

Published in the journal Frontiers in Microbiology, the researchers find that the novel coronavirus presents little variability, which means that the treatments and vaccines being developed...

COVID-19 Vaccine Development: Only Three Vaccine Candidate In Phase III Across World

Coronavirus Vaccine4 years ago

COVID-19 Vaccine Development: Only Three Vaccine Candidate In Phase III Across World

According to a health ministry official, three coronavirus vaccine candidates are from the United States of America, United Kingdom and China can proceed for manufacturing once...

COVID-19 Vaccine Likely To Come By First Half Of 2021, Says WHO Chief Scientist Dr Soumya Swaminathan

Coronavirus Vaccine4 years ago

COVID-19 Vaccine Likely To Come By First Half Of 2021, Says WHO Chief Scientist Dr Soumya Swaminathan

World Health Organization’s Chief scientist, Dr Soumya Swaminathan tells NDTV that the ongoing vaccination development process by several institutes and organisations are ‘so far so good’ as...

Coronavirus Vaccine4 years ago

Coronavirus Vaccine: Oxford University’s COVID-19 Vaccine Candidate Exhibits Strong Immune Responses, Says The Lancet Study

According to the data published in The Lancet, the first phase of human trial of the vaccine candidate ChAdOx1 nCoV-19 developed at the University of Oxford...

Serum Institute To Produce COVID-19 Vaccine Candidate Developed By Oxford University, Will Be Called Covishield In India

Coronavirus Vaccine4 years ago

Serum Institute To Produce COVID-19 Vaccine Candidate Developed By Oxford University, Will Be Called Covishield In India

Serum Institute of India could make the COVID-19 vaccine candidate - ChAdOx1 nCoV-19, being developed by the Oxford University, available in India in November, according to...

Coronavirus Vaccine4 years ago

Phase II Trial Finds Chinese COVID-19 Vaccine Is Safe, Induces Immune Response: Lancet Study

According to researchers, while the Chinese COVID-19 Vaccine candidate can induce immune response, it is not possible to determine whether it will protect against SARS-CoV-2 infection...

COVID-19 Vaccine Likely By End Of This Year Or Early Next Year: AIIMS Doctor

Coronavirus Outbreak4 years ago

COVID-19 Vaccine Likely By End Of This Year Or Early Next Year: AIIMS Doctor

All India Institute of Medical Sciences (AIIMS) Delhi is conducting the human clinical trial of the indigenously developed COVID-19 vaccine Covaxin

Coronavirus Outbreak4 years ago

Clinical Trials Of COVID-19 Vaccine, Covaxin Begins At Goa; To Start At Bhubaneswar From July 22

Covaxin is one of the first indigenous vaccine developed against COVID-19 and is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology (NIV),...

Serum Institute Of India Partners With The Gates Foundation For Manufacturing 100 Million Doses Of COVID-19 Vaccine

COVID-19 Vaccine Not Designed To Eradicate The Virus But To Mitigate The Virus: Expert

DCGI Gives Nod To Serum Institute To Hold Phase II, III COVID Vaccine Trials

A Modern Technique, eVIN, Ensured Essential Immunisation Services: Healthy Ministry

Hope For Vaccine: Novel Coronavirus Strains Show Little Variability, Study Finds

COVID-19 Vaccine Development: Only Three Vaccine Candidate In Phase III Across World

COVID-19 Vaccine Likely To Come By First Half Of 2021, Says WHO Chief Scientist Dr Soumya Swaminathan

Coronavirus Vaccine: Oxford University’s COVID-19 Vaccine Candidate Exhibits Strong Immune Responses, Says The Lancet Study

Serum Institute To Produce COVID-19 Vaccine Candidate Developed By Oxford University, Will Be Called Covishield In India

Phase II Trial Finds Chinese COVID-19 Vaccine Is Safe, Induces Immune Response: Lancet Study

COVID-19 Vaccine Likely By End Of This Year Or Early Next Year: AIIMS Doctor

Clinical Trials Of COVID-19 Vaccine, Covaxin Begins At Goa; To Start At Bhubaneswar From July 22

Highlights: Banega Swasth India Launches Season 10

Reckitt’s Commitment To A Better Future

Self Care For New Moms And Kids Under Five, An Initiative By Reckitt Joins Forces With Government’s ‘Stop Diarrhoea Campaign’

Press Release: Mortein Celebrates World Malaria Day 2024 In Bareilly, Intensifies Efforts To Make Bareilly Malaria-Free

World Malaria Day Special

OHO Hill Yatra Campaign Presented By Dettol Banega Swasth India – Dettol Climate Resilient School Witnessed A Grand Finale In Dehradun

India’s Unsung Heroes

This 34-Year-Old Doctor Is Delivering Healthcare At The Doorstep Of Senior Citizens With ‘Doctor On Wheels’

This Padma Awardee Is Ensuring ‘Health For All’ With Free Healthcare Services In Rural Parts Of Sundarbans

How Can India Improve Neonatal And Maternal Health? Padma Bhushan, Dr Neelam Kler Explains

“Hygiene Is The First Step Of Preventive Healthcare,” Says Padma Shri Prof. (Dr) Indira Chakravarty

Decoding Gut Health With Padma Awardee Dr Nageshwar Reddy